Literature DB >> 8673294

Is there a paradigm shift in genetics? Lessons from the study of human diseases.

K M Weiss1.   

Abstract

The flood of genetic data made possible by recent technological advances has led to a number of important changes in our conceptual model, or working "paradigm," of genetics. Among these changes are recognition that (1) most mutations are unique; (2) there are many alleles at every locus, not just two; (3) these alleles have a hierarchical, or cladistic, history-dependent structure and geographic distribution; (3) the genotype-to-phenotype relationship is complex and quantitative, even for single-locus traits; (4) genotype-phenotype relationships often depend on the organization of the genome into linkage groups, gene families, and the like; and (5) genes affecting quantitative traits can be individually identified rather than solely being viewed as a polygenic aggregate, and these genes each have the same characteristics as genes for single-locus phenotypes. The latter provides a profound unifying impact on biology by reconciling long-standing conceptual differences on qualitative vis-a-vis quantitative phenotypes and their relative importance and evolution. Many of the data that have led to these advances have been generated in the study of genes associated with diseases in human populations. The conceptual changes affect all of biology, but are especially important in the human context, because the amount, complexity, and historical dependence of the variation in the human genome have serious societal implications regarding the epistemology of genetic causation and applications in public health. But whether these changes constitute a real "paradigm shift" in genetics, or are merely adjustments in the classical models developed early in this century, is unclear.

Entities:  

Mesh:

Year:  1996        PMID: 8673294     DOI: 10.1006/mpev.1996.0019

Source DB:  PubMed          Journal:  Mol Phylogenet Evol        ISSN: 1055-7903            Impact factor:   4.286


  7 in total

1.  Scientific limitations and ethical ramifications of a non-representative Human Genome Project: African American response.

Authors:  Fatimah Jackson
Journal:  Sci Eng Ethics       Date:  1998-04       Impact factor: 3.525

2.  A large-sample QTL study in mice: I. Growth.

Authors:  Joao L Rocha; Eugene J Eisen; L Dale Van Vleck; Daniel Pomp
Journal:  Mamm Genome       Date:  2004-02       Impact factor: 2.957

Review 3.  Garrod's foresight; our hindsight.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

4.  A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci.

Authors:  I Hovatta; T Varilo; J Suvisaari; J D Terwilliger; V Ollikainen; R Arajärvi; H Juvonen; M L Kokko-Sahin; L Väisänen; H Mannila; J Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

5.  Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations.

Authors:  E Kayaalp; E Treacy; P J Waters; S Byck; P Nowacki; C R Scriver
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

6.  Clinical features associated with an Asp380His Myocilin mutation in a US family with primary open-angle glaucoma.

Authors:  Mary K Wirtz; John R Samples; Dongseok Choi; N Donna Gaudette
Journal:  Am J Ophthalmol       Date:  2007-05-11       Impact factor: 5.258

7.  Genetic variation and pharmacogenomics: concepts, facts, and challenges.

Authors:  Margret R Hoehe; Thomas Kroslak
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.